Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer

NIH will host a virtual workshop on July 31, 2023, to discuss policies and practices that shape biomedical innovation and promote access to NIH-funded discoveries. Goals will include discussing how NIH, as a research institution, approaches the patenting and licensing of biomedical inventions.  There will also be discussion on the agency’s role in the broader biomedical research enterprise in promoting the application of knowledge to enhance human health.



Meeting Agenda

Background Information

Information on Providing Comments

We invite members of the public to submit written comments on the topic of this workshop. For those wishing to make written comments, please submit those comments to [email protected] by August 18, 2023, so that they may be considered prior to preparing the report of this workshop. The comments we receive may be posted to the OSP website without redaction. As such, please do not include any information in your comments that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should also not be included in your comments.

Public Comments

Compiled Set of Written Comments (June 28 – August 19, 2023)

Final Report

Transforming Discoveries Into Products: Maximizing Levers to Catalyze technology Transfer

Slide Presentations

NIH Guidelines: Honoring the Past, Charting the Future

On July 18-19, 2017, the NIH Office of Science Policy held a workshop on the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.  The goals of the workshop were to examine the current biosafety oversight framework, and discuss the future direction of biosafety oversight in light of the emergence of new technologies in the life sciences and the evolution in our understanding of risk and safety.

Questions about the workshop may be sent to [email protected].


Asilomar ’75: The Beginning of the Future

A retrospective video from some of the participants of the landmark “International Congress on Recombinant DNA Molecules” (aka Asilomar Conference) regarding the legacy of that historical event.


Welcome and Introduction

Session I – David Baltimore, Ph.D.

Session II – Jessica Tucker, Ph.D.

Session II – Stephen J. Libby, Ph.D.

Session II – Hans-Peter Kiem, M.D., Ph.D.

Session III – Deborah E. Wilson, RADM, DrPH, CBSP

Session III – Samuel Edwin, Ph.D.

Session III – Thomas Nerad, MPH, Ph.D.

Session IV – Zach Adelman, Ph.D.


Attendees may view the meeting remotely by visiting, or clicking on the links below:

Day 1:

Day 2: